Towards Healthcare
Connected Drug Delivery Devices Market Leads by 23.44% CAGR by 2034

Connected Drug Delivery Devices Market is Redefining Patient Care

According to market projections, the connected drug delivery devices sector is expected to grow from USD 7.44 billion in 2024 to USD 61.08 billion by 2034, reflecting a CAGR of 23.44%. The rising prevalence of chronic disorders and the growing demand for targeted therapy bolster market growth. North America dominated due to technological advancements and the need for personalized medicines.

Content

  • Insight Code: 5736
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The connected drug delivery devices market is projected to reach USD 61.08 billion by 2034, growing at a CAGR of 23.44% from 2025 to 2034.

North America is leading the connected drug delivery devices market due to the rising adoption of advanced technologies, the presence of key players, and increasing investments.

The connected drug delivery devices market includes 4 segments including by product type, by route of administration, by application, and by region.

Some key players include Aptar Digital Health, Medtronic, SHL Medical, and Ypsomed Holding.

Key trends include the growing demand for telemedicine, the rapidly expanding medical device sector, and the increasing use of AI and ML in the healthcare sector.

A drug can be delivered into the body via the oral route, inhalation route, absorption through the skin, and parenteral route.

Smart drug delivery devices are embedded with sensors and other advanced features to control drug release and improve accuracy, while connected devices can communicate data with healthcare professionals.

Canadian Public Health Association, Press Information Bureau, BfArM
Any Questions